Abstract:Experimental Biology and Medicine, Ahead of Print. In recent years, with the increase of air pollution, smoking, aging, and respiratory infection, the incidence rate and mortality of lung diseases are increasing annually, which has become a major hazard to human health. N6-methyladenosine (m6A) RNA methylation is the most abundant modifications in eukaryotes, and such modified RNA can be specifically recognized and combined by m6A recognition proteins and then mediate RNA splicing, maturation, enucleation, degradation, and translation. More and more studies have revealed that the m6A modification is involved in the pathogenesis and development of some diseases; however, the mechanisms of m6A in lung diseases are poorly understood. In this review, we summarize the latest progress in the biological function of m6A modifications in lung diseases and discuss the potential therapeutic and prognostic strategies. The dysregulation of global m6A levels and m6A regulators may affect the occurrence and development of asthma, chronic obstructive pulmonary disease, lung cancer, and other lung diseases through inflammation and immune function. In lung cancer, this modification has an important impact on malignant cell proliferation, migration, invasion, and drug resistance. In addition, abnormally changed m6A-modified proteins in lung cancer tissue samples and circulating tumor cells (CTCs) may be used as diagnostic and prognostic markers of lung cancer. Models composed of multiple m6A regulators can be used to evaluate the risk prediction or prognosis of asthma and pulmonary fibrosis. In general, the in-depth study of m6A modifications is a frontier direction in disease research. It provides novel insights for understanding of the molecular mechanisms underlying disease occurrence, development, and drug resistance, as well as for the development of effective novel therapeutics.

[Research progress in N6-methyladenosine modification in the field of stomatology]

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Research Progress on M6a-Modified Circrna in Oral Diseases

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

The Crucial Roles of N6-methyladenosine (m6a) Modification in the Carcinogenesis and Progression of Colorectal Cancer

[Research progress on the role of N6-methyladenosine methylation in the pathogenesis and development of respiratory diseases]

The crucial roles of N 6 -methyladenosine (m 6 A) modification in the carcinogenesis and progression of colorectal cancer

Research progress on the role of N6-methyladenosine ( m6A) RNA modification in reproductive system diseases

Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology

N6-Methyladenosine-Modification-Related Ophthalmic Diseases and Potential Therapeutic Strategies

The N6-Methyladenosine Modification and Its Role in Mrna Metabolism and Gastrointestinal Tract Disease

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis

RNA M6a Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications.

The essential roles of m6A modification in osteogenesis and common bone diseases

Current researches on N6-methyladenosine and its functions in solid tumors

Research progress of m6A regulation during animal growth and development

Emerging Role of M6a Modification in Osteogenesis of Stem Cells

Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer

Emerging role of N6-methyladenosine RNA methylation in lung diseases

Potential applications of N6 -methyladenosine modification in the prognosis and treatment of cancers via modulating apoptosis, autophagy, and ferroptosis